Eidogen-Sertanty is dedicated to helping scientists discover new medicines with innovative software technology and knowledgebases. Through the integration of advanced ligand-based and structure-based informatics techniques, Eidogen-Sertanty's software and solutions effectively bridge the knowledge gap between biology and chemistry.

Our major discovery informatics platforms TIP™, ChIP™, Kinase Knowledgebase™, and ARK™ allow our pharmaceutical clients and partners to leverage public and proprietary chemical and structural knowledge to substantially improve the overall efficiency of the drug discovery cycle from hit to lead, increasing the odds and lowering the costs of successfully developing novel, safe, and effective medicines.

Our DirectDesign™ Discovery Service combines all of our proprietary technologies for the directed de novo design of lead compounds and target-focused virtual libraries. Our biotechnology and pharmaceutical clients utilize DirectDesign to fully exploit the complete spectrum of Eidogen-Sertanty's knowledge-driven discovery informatics capabilities on a project-by-project basis.